Skip to main content

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

KLRS holding history

Kalaris Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KLRS overviewAll 13F holders of KLRSFull Q2 2026 holdings

Shares (Q2 2026)
15,958
Value
$65.0K
% of portfolio
<0.1%
Quarters held
14
Since Q4 2021
Holdings of KLRS by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,958$65.0K<0.1%+15,958NewHolders
Q1 20250$00.0%−3,033−100.0%Sold outConverted for a 1-for-23 splitHolders
Q4 202469,769$29.5K<0.1%00.0%UnchangedHolders
Q3 202469,769$56.3K<0.1%00.0%UnchangedHolders
Q2 202469,769$50.8K<0.1%00.0%UnchangedHolders
Q1 202469,769$52.7K<0.1%−1,400−2.0%ReducedHolders
Q4 202371,169$48.4K<0.1%−42,765−37.5%ReducedHolders
Q3 2023113,934$245.4K<0.1%−118,659−51.0%ReducedHolders
Q2 2023232,593$791.1K<0.1%−67,952−22.6%ReducedHolders
Q1 2023300,545$1.18M<0.1%+174,246+138.0%AddedHolders
Q4 2022126,299$648.0K<0.1%+61,907+96.1%AddedHolders
Q3 202264,392$508.0K<0.1%−26,720−29.3%ReducedHolders
Q2 202291,112$356.0K<0.1%+20,725+29.4%AddedHolders
Q1 202270,387$476.0K<0.1%+21,337+43.5%AddedHolders
Q4 202149,050$635.0K<0.1%+49,050NewHolders